Demographics and microbiological profile of pneumonia in United Arab Emirates

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 65, Issue 1, 2006, Pages 13-18

  Al Muhairi, S ^a   Zoubeidi, T ^b   Ellis, M ^a   Nicholls, M Gary ^a   Safa, W ^c   Joseph, J ^a,d  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c TAWAM HOSPITAL   (United Arab Emirates)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Community acquired pneumonia; Drug resistance; Hospital acquired pneumonia; Pneumococcal pneumonia; Seasonal trends in pneuomonia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; PIPERACILLIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL STUDY; COMMUNITY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; PATIENT CARE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEASONAL VARIATION; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; UNITED ARAB EMIRATES; UNIVERSITY HOSPITAL;

EID: 33646424093     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2006.580     Document Type: Article

References (21)

1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-1624.
2. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002; 36: 20s-27s.
3. Kurashi NY, al Hamdan A, Ibrahim EM, et al. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax 1992; 47: 115-118.
4. Sangthawan P, Chantaratchada S, Chanthadisai N, Wattanathum A. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand. Respirology 2003; 8: 208-212.
5. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
6. Polk R. Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 1999; 29: 264-274.
7. Ashworth M, Latinovic R, Charlton J, et al. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health (Oxf) 2004; 26: 268-274.
8. Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 2003; 53: 778-783.
9. Shah PB, Giudice JC, Griesback R, Jr, et al. The newer guidelines for the management of community-acquired pneumonia. J Am Osteopath Assoc 2004; 104: 521-526.
10. Lieberman D, Lieberman D, Porath A. Seasonal variation in community-acquired pneumonia. Eur Respir J 1996; 9 (12): 2630-2634.
11. Lieberman D, Lieberman D, Friger MD. Seasonal variation in hospital admissions for community-acquired pneumonia: a 5-year study. J Infect 1999; 39: 134-140.
12. Halliday L, Roberts L, Hampson A. Annual report of the National Influenza Surveillance Scheme, 1998. Commun Dis Intell 1999; 23: 185-192.
13. Roche P, Spencer J, Merianos A, Hampson A. Annual report of the National Influenza Surveillance Scheme, 2000. Commun Dis Intell 2001; 25: 107-112.
14. Saynajakangas P, Keistinen T, Tuuponen T. Seasonal fluctuations in hospitalisation for pneumonia in Finland. Int J Circumpolar Health 2001; 60: 34-40.
15. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: 296-301.
16. Lieberman D, Schlaeffer F, Lieberman D, et al. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration 1996; 63: 261-266.
17. Howard LS, Sillis M, Pasteur MC, et al. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect 2005; 50: 107-113.
18. Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest 2003; 123: 1512-1519.
19. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-184.
20. Zhanel GG, Palatnick L, Nichol KA, et al. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1867-1874.
21. Zhanel GG, Palatnick L, Nichol KA, et al. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1875-1881.